Metabolomics is referred as the large-scale study of small molecules, commonly known as metabolites, within tissues, cells, biofluids or organisms.

Scope of the Report:

Innovative development in informatics and analytical technologies and increasing pharmaceutical and biotech R&D expenditure are expected to significantly contribute in the market growth during forecast period. Other factors such as ongoing research on metabolomics biomarker and extensive application of metabolomics biomarker such as in colorectal cancer detection are also expected to drive the market growth. Further, increasing pharmaceutical and biotech R&D expenditure is also contributing in the market.

The global Metabolomics Biomarker market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Metabolomics Biomarker.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Metabolomics Biomarker market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Metabolomics Biomarker market by product type and applications/end industries.

Market Segment by Companies, this report covers

Biocrates Life Sciences

Biomark Diagnostics

Chenomx

Creative Proteomics

Evotec

Human Metabolome Technologies

Merck

Metabolomic Diagnostics

Metabolon

Ovid Therapeutics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Gas chromatography

High-performance liquid chromatography

Ultra-performance liquid chromatography

Nuclear magnetic resonance

Mass spectrometry

Surface-based mass analysis

Bioinformatics

Market Segment by Applications, can be divided into

Toxicological studies

Drug testing

Cancer

Cardiovascular disorders

Neurological disorders

Inborn errors of metabolism

Table of Contents

1 Metabolomics Biomarker Market Overview

1.1 Product Overview and Scope of Metabolomics Biomarker

1.2 Classification of Metabolomics Biomarker by Types

1.2.1 Global Metabolomics Biomarker Revenue Comparison by Types (2017-2023)

1.2.2 Global Metabolomics Biomarker Revenue Market Share by Types in 2017

1.2.3 Gas chromatography

1.2.4 High-performance liquid chromatography

1.2.5 Ultra-performance liquid chromatography

1.2.6 Nuclear magnetic resonance

1.2.7 Mass spectrometry

1.2.8 Surface-based mass analysis

1.2.9 Bioinformatics

1.3 Global Metabolomics Biomarker Market by Application

1.3.1 Global Metabolomics Biomarker Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Toxicological studies

1.3.3 Drug testing

1.3.4 Cancer

1.3.5 Cardiovascular disorders

1.3.6 Neurological disorders

1.3.7 Inborn errors of metabolism

1.4 Global Metabolomics Biomarker Market by Regions

1.4.1 Global Metabolomics Biomarker Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Metabolomics Biomarker Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Metabolomics Biomarker Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metabolomics Biomarker Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Metabolomics Biomarker Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metabolomics Biomarker Status and Prospect (2013-2023)

1.5 Global Market Size of Metabolomics Biomarker (2013-2023)

2 Manufacturers Profiles

2.1 Biocrates Life Sciences

2.1.1 Business Overview

2.1.2 Metabolomics Biomarker Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Biocrates Life Sciences Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

2.2 Biomark Diagnostics

2.2.1 Business Overview

2.2.2 Metabolomics Biomarker Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Biomark Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

2.3 Chenomx

2.3.1 Business Overview

2.3.2 Metabolomics Biomarker Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Chenomx Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

2.4 Creative Proteomics

2.4.1 Business Overview

2.4.2 Metabolomics Biomarker Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Creative Proteomics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

2.5 Evotec

2.5.1 Business Overview

2.5.2 Metabolomics Biomarker Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Evotec Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

2.6 Human Metabolome Technologies

2.6.1 Business Overview

2.6.2 Metabolomics Biomarker Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Human Metabolome Technologies Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck

2.7.1 Business Overview

2.7.2 Metabolomics Biomarker Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

2.8 Metabolomic Diagnostics

2.8.1 Business Overview

2.8.2 Metabolomics Biomarker Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Metabolomic Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

2.9 Metabolon

2.9.1 Business Overview

2.9.2 Metabolomics Biomarker Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Metabolon Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

2.10 Ovid Therapeutics

2.10.1 Business Overview

2.10.2 Metabolomics Biomarker Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Ovid Therapeutics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

3 Global Metabolomics Biomarker Market Competition, by Players

3.1 Global Metabolomics Biomarker Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Metabolomics Biomarker Players Market Share

3.2.2 Top 10 Metabolomics Biomarker Players Market Share

3.3 Market Competition Trend

4 Global Metabolomics Biomarker Market Size by Regions

4.1 Global Metabolomics Biomarker Revenue and Market Share by Regions

4.2 North America Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

4.3 Europe Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

4.5 South America Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

5 North America Metabolomics Biomarker Revenue by Countries

5.1 North America Metabolomics Biomarker Revenue by Countries (2013-2018)

5.2 USA Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

5.3 Canada Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

5.4 Mexico Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

6 Europe Metabolomics Biomarker Revenue by Countries

6.1 Europe Metabolomics Biomarker Revenue by Countries (2013-2018)

6.2 Germany Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

6.3 UK Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

6.4 France Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

6.5 Russia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

6.6 Italy Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Metabolomics Biomarker Revenue by Countries

7.1 Asia-Pacific Metabolomics Biomarker Revenue by Countries (2013-2018)

7.2 China Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

7.3 Japan Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

7.4 Korea Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

7.5 India Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

8 South America Metabolomics Biomarker Revenue by Countries

8.1 South America Metabolomics Biomarker Revenue by Countries (2013-2018)

8.2 Brazil Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

8.3 Argentina Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

8.4 Colombia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Metabolomics Biomarker by Countries

9.1 Middle East and Africa Metabolomics Biomarker Revenue by Countries (2013-2018)

9.2 Saudi Arabia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

9.3 UAE Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

9.4 Egypt Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

9.5 Nigeria Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

9.6 South Africa Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

10 Global Metabolomics Biomarker Market Segment by Type

10.1 Global Metabolomics Biomarker Revenue and Market Share by Type (2013-2018)

10.2 Global Metabolomics Biomarker Market Forecast by Type (2018-2023)

10.3 Gas chromatography Revenue Growth Rate (2013-2023)

10.4 High-performance liquid chromatography Revenue Growth Rate (2013-2023)

10.5 Ultra-performance liquid chromatography Revenue Growth Rate (2013-2023)

10.6 Nuclear magnetic resonance Revenue Growth Rate (2013-2023)

10.7 Mass spectrometry Revenue Growth Rate (2013-2023)

10.8 Surface-based mass analysis Revenue Growth Rate (2013-2023)

10.9 Bioinformatics Revenue Growth Rate (2013-2023)

11 Global Metabolomics Biomarker Market Segment by Application

11.1 Global Metabolomics Biomarker Revenue Market Share by Application (2013-2018)

11.2 Metabolomics Biomarker Market Forecast by Application (2018-2023)

11.3 Toxicological studies Revenue Growth (2013-2018)

11.4 Drug testing Revenue Growth (2013-2018)

11.5 Cancer Revenue Growth (2013-2018)

11.6 Cardiovascular disorders Revenue Growth (2013-2018)

11.7 Neurological disorders Revenue Growth (2013-2018)

11.8 Inborn errors of metabolism Revenue Growth (2013-2018)

12 Global Metabolomics Biomarker Market Size Forecast (2018-2023)

12.1 Global Metabolomics Biomarker Market Size Forecast (2018-2023)

12.2 Global Metabolomics Biomarker Market Forecast by Regions (2018-2023)

12.3 North America Metabolomics Biomarker Revenue Market Forecast (2018-2023)

12.4 Europe Metabolomics Biomarker Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Metabolomics Biomarker Revenue Market Forecast (2018-2023)

12.6 South America Metabolomics Biomarker Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Metabolomics Biomarker Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Metabolomics Biomarker Picture

Table Product Specifications of Metabolomics Biomarker

Table Global Metabolomics Biomarker and Revenue (Million USD) Market Split by P